Organogenesis closes $100 million two-part credit facility

By Wendy Van Sickle

Columbus, Ohio, March 14 – Organogenesis Holdings Inc. closed a new $100 million credit agreement with Silicon Valley Bank as lead agent and MidCap Financial, according to a news release.

The credit facility comprises a $60 million term loan facility and a $40 million revolving credit facility.

The agreement contains financial covenants and requires achievement of certain financial milestones in order to draw the final $20 million of the term loan facility.

Proceeds will be used for general corporate purposes and the repayment of the company’s existing credit facility and a lease with Eastward Capital Partners.

The regenerative medicine company offers a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.